BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Beach

  UCSD John B. West Distinguished Lecture Series, Sponsored by MediPines, to Feature Nobel Laureate Dr. Gregg L. Semenza

  MediPines, the pioneering market leader in non-invasive pulmonary gas exchange technology, and maker of AGM100, will sponsor this year’s annual UCSD John B. West Distinguished Lecture event featuring Nobel Laureate Gregg L. Semenza, MD, PhD.

  August 2, 2023

   · 

  2 min read
• Biotech Beach

  Nymox Announces $2 Million Private Placement

  Nymox Pharmaceutical Corporation is pleased to announce an investment of US $2.0 million for 2 million shares at the price of $1.00 per share with 500,000 warrants priced at $2.00.

  August 2, 2023

   · 

  3 min read
• Business

  Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2023 Financial Results

  Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2023 on Wednesday, Aug. 9 at 9 a.m., ET.

  August 2, 2023

   · 

  1 min read
• Synaptive Medical Welcomes Provincial Investment to Expand Manufacturing and R&D Activities

  Synaptive Medical has received $900,000 in support from the Ontario government through the Ontario Together Fund.

  August 2, 2023

   · 

  2 min read
• Pharm Country

  Y-mAbs to Participate at Upcoming Investor Conferences - August 02, 2023

  Y-mAbs Therapeutics, Inc. announced that the Company will participate at the following upcoming investor conferences.

  August 2, 2023

   · 

  4 min read
• Business

  Corcept Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update

  Corcept Therapeutics Incorporated, a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism and neurology disorders by modulating the effects of the hormone cortisol, reported results for the quarter ended June 30, 2023.

  August 2, 2023

   · 

  10 min read
• Business

  Nanox to Report Second Quarter 2023 Financial Results on August 17, 2023

  NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX) will report its financial results for the second quarter ended June 30, 2023 before market open on Thursday, August 17, 2023.

  August 2, 2023

   · 

  4 min read
• Business

  Inari Medical Reports Second Quarter 2023 Financial Results

  Inari Medical, Inc. reported financial results for its second quarter ended June 30, 2023.

  August 2, 2023

   · 

  7 min read
• Biotech Bay

  Tenaya Therapeutics to Participate at the 43rd Annual Canaccord Genuity Growth Conference

  Tenaya Therapeutics, Inc. announced that Tenaya senior management will participate in the 43rd Annual Canaccord Genuity Growth Conference taking place in Boston.

  August 2, 2023

   · 

  1 min read
• Biotech Bay

  PacBio Begins Commercialization of the Onso Short-Read Sequencing System

  PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced that customer shipments of Onso short-read sequencing instruments will commence.

  August 2, 2023

   · 

  7 min read